CymitQuimica logo

Fluoxetine-Conjugated Platinum(IV) prodrug-1

Ref. TM-T207715

CymitQuimica logo
Targetmol

Product Information

Name:Fluoxetine-Conjugated Platinum(IV) prodrug-1
Brand:Targetmol
Description:Fluoxetine-Conjugated Platinum(IV) prodrug-1 is an eEF2K inhibitor that can hinder the proliferation of cancer cells, induce DNA damage, and cause cell cycle arrest at the S phase, leading to apoptosis (Apoptosis). It also promotes the accumulation of reactive oxygen species (ROS) and disrupts mitochondrial function. This prodrug inhibits the migration and invasion of TNBC cells by suppressing MMP-2 activity and induces autophagy in TNBC cells through AMPK activation. In the 4T1-Luc mouse model, it exhibits antitumor activity and triggers immune suppression. Fluoxetine-Conjugated Platinum(IV) prodrug-1 is relevant for research in triple-negative breast cancer (TNBC).
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:724.1006
Formula:C21H28Cl2F3N3O5Pt
Color/Form:Solid

Technical inquiry about: Fluoxetine-Conjugated Platinum(IV) prodrug-1

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.